This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02113/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB02113/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02113/identifier/pubchem-compound/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02113/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02113/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02113
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB02113 n14:DB02113
dcterms:title
6-Methylpurine
adms:identifier
n6:DB02113 n7:6MP n8:4449900 n12:5287547 n13:46506443
n3:IUPAC-Name
n4:271B3EEB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3EF1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3EF0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3EED-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3EEE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3EEF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3F01-363D-11E5-9242-09173F13E4C5 n4:271B3EE9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3EE7-363D-11E5-9242-09173F13E4C5 n4:271B3EEA-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3EE8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3EF7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3EF8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3EF2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3EF3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3EF5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3EF4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3EF6-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
2004-03-7
n3:Bioavailability
n4:271B3EFD-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3EFF-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3F00-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3EFC-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3EFB-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3EFE-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3EEC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3EF9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3EFA-363D-11E5-9242-09173F13E4C5